OmniVision Technologies, Inc. Provides Disposable Cameras for Next Generation Medical Intubation System ETView Selects Ultra Small OV6920 Medical Sensor for New FDA-Approved TVT

SANTA CLARA, Calif., Sept. 29 /PRNewswire-FirstCall/ -- OmniVision Technologies, Inc. , a leading developer of advanced digital imaging solutions, today announced that its ultra small OV6920 medical image sensor has been selected for ETView’s new TVT Tracheoscopic Ventilation Tube. The OV6920 is a small footprint, market ready medical sensor offering best-in-class low-light sensitivity and an excellent cost-performance ratio, making it ideal for ETView’s disposable medical devices.

“OmniVision and ETView have a strong business relationship, having worked together on their first generation TVT,” said Zafer Zamboglu, senior marketing manager for medical device marketing at OmniVision Technologies. “Being familiar with ETView’s specific requirements for products used in medical applications, OmniVision was able to deliver a product that could offer superior imaging capabilities while meeting the strict regulatory requirements for medical devices.”

“OmniVision was the first to offer an off-the-shelf image sensor for the disposable medical market,” said Elias Daher, research and development engineer for ETView. “OmniVision’s solution saved us considerable development time and costs, offering us a strong competitive advantage. The analog OV6920 enabled us to bring to market a product with a user-friendly interface. With an analog video signal to connect the TVT to any existing video monitor, the OV6920 eliminates the requirement for a specialty viewing system and further reduces system costs.”

The OV6920 is among the world’s smallest available NTSC CMOS image sensors. The sensor’s 2.5 X 2.5 micron pixel size enables a tiny camera package with an impressive resolution. ETView’s TVT, together with the OV6920, offers doctors the ability to maintain a continuous view during intubation. Furthermore, the TVT camera’s 4 mm outer diameter is ideal for medical applications in terms of promoting patient comfort. Once the TVT is placed inside the trachea, it monitors the upper airways in real time and can remain in the patient for up to 14 days.

The OV6920 is an ideal solution for cost-effective applications requiring both excellent color video performance and a very small footprint. The ultra small OV6920 is a single-chip OmniPixel2 camera chip system, which needs only clock and power to get the national television system(s) committee (NTSC) composite signal out for direct interface with a VCR/TV/monitor. The OV6920 is designed for very low power consumption, requiring only a single 3.3-volt DC supply.

About OVT Medical Imaging Solutions

OmniVision is a supplier of CMOS imaging solutions to the medical market with a proven track record in delivering industry-first innovative solutions. Applying over a decade of industry knowledge, experience, and proven technology, OmniVision’s rich portfolio provides today’s medical designers with a broad selection of sensors, evaluation kits and development platforms to improve time-to-market and substantially reduce overall system cost. With offices and dedicated staff around the globe, OmniVision provides unrivalled customer support. For more information on OmniVision solutions for the medical market, visit www.ovt.com/medical.

About OmniVision

OmniVision Technologies is a leading developer of advanced digital imaging solutions. Its award-winning CMOS imaging technology enables superior image quality in many of today’s consumer and commercial applications, including mobile phones, notebooks, netbooks and webcams, digital still and video cameras, security and surveillance, automotive and medical imaging systems. Find out more at www.ovt.com.

Safe-Harbor Language

Certain statements in this press release, including statements regarding the performance and capabilities of OmniVision medical imaging technology and devices are forward-looking statements that are subject to risks and uncertainties. These risks and uncertainties, which could cause the forward-looking statements and OmniVision’s results to differ materially, include, without limitation: potential errors, design flaws or other problems with the OmniVision technology and other risks detailed from time to time in OmniVision’s Securities and Exchange Commission filings and reports, including, but not limited to, OmniVision’s most recent annual report filed on Form 10-K and its most recent quarterly reports filed on Form 10-Q. OmniVision expressly disclaims any obligation to update information contained in any forward-looking statement.

OmniVision(R), OmniPixel(R) and TrueFocus(R) are registered trademarks of OmniVision Technologies, Inc. The OmniVision logo, CameraChip(TM), CameraCube(TM), OmniBSI(TM), OmniPixel2(TM), OmniPixel3(TM) and OmniPixel3-HS(TM) are trademarks of OmniVision Technologies, Inc. All other trademarks are the property of their respective owners.

SOURCE OmniVision Technologies, Inc.

CONTACT: media, Martijn Pierik, Impress Public Relations, +1-602-366-5599,
martijn@impress-pr.com; or company, Scott Foster, OmniVision Technologies,
+1-408-567-3077, sfoster@ovt.com, or investor relations, Chesha Gibbons,
OmniVision Technologies, +1-408-653-3263, cgibbons@ovt.com, company, Yaron
Samama, ETView, +972-4-9991991, yaron@etview.com

Web site: http://www.ovt.com/

MORE ON THIS TOPIC